Skip to main content
. 2020 Feb 11;2020(2):CD004863. doi: 10.1002/14651858.CD004863.pub6

3.2. Analysis.

3.2

Comparison 3 Darbepoetin alfa or erythropoietin (erythropoiesis‐stimulating agents ‐ ESAs) versus placebo or no treatment, Outcome 2 BSID‐III composite language score at 18 to 22 months.